Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pasquini

Showing results (131-140 of 228) with videos related to

Pageof 23
Sort By:
Bone Marrow Transplantation|April 15, 2020
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantationLuciano J Costa, Simona Iacobelli, Marcelo C Pasquini, et al.
Blood|October 2, 2013
Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantationChristopher Bredeson, Jennifer LeRademacher, Kazunobu Kato, et al.
American Journal of Hematology|May 14, 2022
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myelomaAnita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, et al.
Transplantation and Cellular Therapy|November 14, 2025
CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World SettingBradley D Hunter, Matthew Lunning, Mazyar Shadman, et al.
Leukemia|February 24, 2025
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702Rahul Banerjee, Amber R Fritz, Othman S Akhtar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2020
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival OutcomesSaurabh Chhabra, Ravi K Narra, Ruizhe Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2010
Second unrelated donor hematopoietic cell transplantation for primary graft failureJeffrey Schriber, Manza-A Agovi, Vincent Ho, et al.
Bone Marrow Transplantation|December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantationG Akpek, M C Pasquini, B Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2010
Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adultsWillis H Navarro, Manza-A Agovi, Brent R Logan, et al.
Hematological Oncology|September 21, 2024
Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implicationsN Polverelli, M Anghilieri, C Elena, et al.
Pageof 23

Showing results (131-140 of 228) with videos related to

Sort By:
Pageof 23
Bone Marrow Transplantation|April 15, 2020
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantationLuciano J Costa, Simona Iacobelli, Marcelo C Pasquini, et al.
Blood|October 2, 2013
Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantationChristopher Bredeson, Jennifer LeRademacher, Kazunobu Kato, et al.
American Journal of Hematology|May 14, 2022
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myelomaAnita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, et al.
Transplantation and Cellular Therapy|November 14, 2025
CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World SettingBradley D Hunter, Matthew Lunning, Mazyar Shadman, et al.
Leukemia|February 24, 2025
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702Rahul Banerjee, Amber R Fritz, Othman S Akhtar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2020
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival OutcomesSaurabh Chhabra, Ravi K Narra, Ruizhe Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2010
Second unrelated donor hematopoietic cell transplantation for primary graft failureJeffrey Schriber, Manza-A Agovi, Vincent Ho, et al.
Bone Marrow Transplantation|December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantationG Akpek, M C Pasquini, B Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2010
Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adultsWillis H Navarro, Manza-A Agovi, Brent R Logan, et al.
Hematological Oncology|September 21, 2024
Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implicationsN Polverelli, M Anghilieri, C Elena, et al.
Pageof 23